...要 本发明公开了一种检测2型糖尿病易感性的方法,它包括检测个体的胰升糖素样肽-1受体基因(glucagon-like peptide 1 receptor,GLP1R)、转录本和/或蛋白与正常相比是否存在变异,存在变异就表明该个体患2型糖尿病的可能性大于正常人群。
基于4个网页-相关网页
以上来源于: WordNet
Victoza is in a class of medicines known as glucagon-like peptide-1 (GLP-1) receptor agonists that help the pancreas make more insulin after eating a meal.
利拉鲁肽是一种GLP - 1受体激动剂,这类药可在用餐后促使胰腺分泌更多的胰岛素。
BYDUREON and BYETTA belong to the glucagon-like peptide-1 (GLP-1) receptor agonist class of medications.
BYDUREON和百泌达(BYETTA)都属于胰高血糖素样肽(GLP - 1)受体激动剂类药物。
应用推荐